Clinical trial
Oral Androgens in Man-4: (Short Title: Oral T-4)
NCT00399165 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00399165 |
|---|---|
| Title | Oral Androgens in Man-4: (Short Title: Oral T-4) |
| Official title | Oral Androgens in Man-4: Gonadotropin Suppression Medicated by Oral Testosterone Enanthate in Oil Plus Dutasteride (Short Title: Oral T-4) |
| Lead sponsor | University of Washington, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug, Other |
| Interventions | Testosterone Enanthate, Dutasteride, placebo sesame oil |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Nov 14, 2006 |
| Last update posted | Sep 22, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: